NCT01120249-D2
Dataset Information
Dataset ID: NCT01120249-D2
PubMed ID (PMID):
Publication Title:
Adjuvant Everolimus after Surgery for Renal-Cell Carcinoma (EVEREST): A Double-Blind, Placebo-Controlled, Randomised, Phase 3 Trial
Description of Dataset:
This dataset contains the results reported in The Lancet (Ryan et al., The Lancet, 2023). The toxicity dataset contains event-level information (one row per patient per adverse event experience on trial). NCT01120249-D1 contains baseline information and outcome data.
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT01120249 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®